Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study-Reference-Cited by-同舟云学术

Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study

Published:2017-12-27 Issue:12 Volume:14 Page:e1002475
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Johnston Christine^ORCID,Magaret Amalia^ORCID,Roychoudhury Pavitra^ORCID,Greninger Alexander L.^ORCID,Reeves Daniel^ORCID,Schiffer Joshua,Jerome Keith R.^ORCID,Sather Cassandra,Diem Kurt,Lingappa Jairam R.^ORCID,Celum Connie,Koelle David M.^ORCID,Wald Anna^ORCID

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference46 articles.

1. Future prospects for new vaccines against sexually transmitted infections;SL Gottlieb;Curr Opin Infect Dis,2017

2. Status of vaccine research and development of vaccines for herpes simplex virus;C Johnston;Vaccine,2016

3. Correlate of immune protection against HSV-1 genital disease in vaccinated women;RB Belshe;J Infect Dis,2014

4. Efficacy results of a trial of a herpes simplex vaccine;RB Belshe;N Engl J Med,2012

5. patient-specific neutralizing antibody responses to herpes simplex virus are attributed to epitopes on gD, gB, or both and can be type specific;TM Cairns;J Virol,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine value profile for herpes simplex virus;Vaccine;2024-07

2. Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy;Viruses;2022-04-21

3. Alphaherpesvirus Genomics: Past, Present and Future;Current Issues in Molecular Biology;2022

4. A holistic perspective on herpes simplex virus (HSV) ecology and evolution;Advances in Virus Research;2021

5. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection;PLOS Pathogens;2020-07-27